SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Micera, A.
Right arrow Articles by Aloe, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Micera, A.
Right arrow Articles by Aloe, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Altered nerve growth factor level in the optic nerve of patients affected by multiple sclerosis

Alessandra Micera

Institute of Neurobiology, CNR, Viale Marx 43/11, 00137 Rome, Italy

Alessandro Lambiase

Institute of Neurobiology, CNR, Viale Marx 43/11, 00137 Rome, Italy, Department of Ophthalmology, University of 'Tor Vergata', Rome, Italy

Paolo Rama

Division of Ophthalmology, Hospital 'SS Giovanni e Paolo', Venice, Italy

Luigi Aloe

Institute of Neurobiology, CNR, Viale Marx 43/11, 00137 Rome, Italy

In this study we measured with a highly sensitive two-site immunoenzymatic assay the levels of nerve growth factor (NGF) in human optic nerve affected by multiple sclerosis (MS). The result of this study showed an elevated increase of NGF in the MS optic nerves, as compared to the level of NGF found in the optic nerves non-affected by this demyelinating disorder. Moreover, the results showed that the optic nerves also expressed trkA NGF receptor and NGFmRNA, most likely by oligodendrocytes, implying that NGF is locally produced and suggesting that the presence of NGF might be regulated by an autocrine mechanism. These and other ongoing studies on animal models indicate that altered NGF levels are among one of the early symptoms of these demyelinating diseases. The physiopathological role of NGF in the optic nerve during demyelinating disorders remains however to be defined.

Key Words: demyelinating disorders • multiple sclerosis • NGF • NGFmRNA • oligodendrocytes • optic nerve • trkA

Multiple Sclerosis, Vol. 5, No. 6, 389-394 (1999)
DOI: 10.1177/135245859900500i604


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
A. Lambiase, P. Tirassa, A. Micera, L. Aloe, and S. Bonini
Pharmacokinetics of Conjunctivally Applied Nerve Growth Factor in the Retina and Optic Nerve of Adult Rats
Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3800 - 3806.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
F. Levi-Schaffer, A. Micera, E. Zamir, H. Mechoulam, I. Puxeddu, A. M. Piliponsky, L. Aloe, and J. Pe'er
Nerve Growth Factor and Eosinophils in Inflamed Juvenile Conjunctival Nevus
Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 1850 - 1856.
[Abstract] [Full Text] [PDF]



Advertisement